Exosome-based Nanoplatform for Ldlr mRNA Delivery in FH
Exosome-based Nanoplatform for Ldlr mRNA Delivery in FH
Not yet recruiting · NCT05043181 · Registry updated 2021-09-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Exosome-based Nanoplatform for Ldlr mRNA Delivery in FH | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Nutritional and Metabolic Diseases, familial hypercholesterolemia, hereditary disease, hyperlipidemia, hyperlipoproteinemia, inborn errors of metabolism, metabolic disease | Not yet recruiting | Phase 1 | 2021-09-14 | NCT05043181 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Air Force Military Medical University, China | 39 |
| Tang-Du Hospital | 93 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Tangdu Hospital, Air Force Medical University | Xi'an | China | 1 |